181 related articles for article (PubMed ID: 12888594)
1. Significance of macrolide resistance in Streptococcus pneumoniae.
Nuermberger EL; Bishai WR
J Antimicrob Chemother; 2003 Sep; 52(3):524-5; author reply 525. PubMed ID: 12888594
[No Abstract] [Full Text] [Related]
2. Streptococcus pneumoniae bacteraemia: pharmacodynamic correlations with outcome and macrolide resistance--a controlled study.
Schentag JJ; Klugman KP; Yu VL; Adelman MH; Wilton GJ; Chiou CC; Patel M; Lavin B; Paladino JA
Int J Antimicrob Agents; 2007 Sep; 30(3):264-9. PubMed ID: 17587549
[TBL] [Abstract][Full Text] [Related]
3. The clinical significance of macrolide-resistant Streptococcus pneumoniae: it's all relative.
Nuermberger E; Bishai WR
Clin Infect Dis; 2004 Jan; 38(1):99-103. PubMed ID: 14679455
[TBL] [Abstract][Full Text] [Related]
4. Macrolide and ketolide resistance with Streptococcus pneumoniae.
Doern GV
Med Clin North Am; 2006 Nov; 90(6):1109-24. PubMed ID: 17116439
[TBL] [Abstract][Full Text] [Related]
5. Macrolide resistance determinants in erythromycin-resistant Streptococcus pneumoniae in Turkey.
Gulay Z; Ozbek OA; Bicmen M; Gur D
Jpn J Infect Dis; 2008 Nov; 61(6):490-3. PubMed ID: 19050364
[TBL] [Abstract][Full Text] [Related]
6. Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin.
Kelley MA; Weber DJ; Gilligan P; Cohen MS
Clin Infect Dis; 2000 Oct; 31(4):1008-11. PubMed ID: 11049784
[TBL] [Abstract][Full Text] [Related]
7. Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae.
Bergman M; Huikko S; Huovinen P; Paakkari P; Seppälä H;
Antimicrob Agents Chemother; 2006 Nov; 50(11):3646-50. PubMed ID: 16940064
[TBL] [Abstract][Full Text] [Related]
8. Macrolide resistance among invasive Streptococcus pneumoniae in Slovenia.
Kastrin T; Gubina M; Paragi M; Kolman J; Cizman M; Kraigher A; Ribic H; Sadowy E; Hryniewicz W
J Antimicrob Chemother; 2008 Sep; 62(3):628-9. PubMed ID: 18474511
[No Abstract] [Full Text] [Related]
9. Evolution of macrolide resistance in Streptococcus pneumoniae clinical isolates in the prevaccine era.
Daikos GL; Koutsolioutsou A; Tsiodras S; Theodoridou M; Koutouzis EI; Charissiadou A; Pangalis A; Michos AG; Chaidopoulou F; Braoudaki M; Syriopoulou VP
Diagn Microbiol Infect Dis; 2008 Apr; 60(4):393-8. PubMed ID: 18077121
[TBL] [Abstract][Full Text] [Related]
10. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002.
Farrell DJ; Jenkins SG
J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i17-22. PubMed ID: 15265832
[TBL] [Abstract][Full Text] [Related]
11. A review of clinical failures associated with macrolide-resistant Streptococcus pneumoniae.
Rzeszutek M; Wierzbowski A; Hoban DJ; Conly J; Bishai W; Zhanel GG
Int J Antimicrob Agents; 2004 Aug; 24(2):95-104. PubMed ID: 15288306
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibilities and distribution of resistance genes for beta-lactams and macrolides in Streptococcus pneumoniae isolated between 2002 and 2004 in Tokyo.
Noguchi N; Tano J; Nasu Y; Koyama M; Narui K; Kamishima H; Saito T; Tsuyuki K; Sasatsu M
Int J Antimicrob Agents; 2007 Jan; 29(1):26-33. PubMed ID: 17189091
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic susceptibility according to genotype of penicillin-binding protein and macrolide resistance genes, and serotype of Streptococcus pneumoniae isolates from community-acquired pneumonia in children.
Chiba N; Kobayashi R; Hasegawa K; Morozumi M; Nakayama E; Tajima T; Iwata S; Ubukata K;
J Antimicrob Chemother; 2005 Oct; 56(4):756-60. PubMed ID: 16131518
[TBL] [Abstract][Full Text] [Related]
14. Clonal spread of mef-positive macrolide-resistant Streptococcus pneumoniae isolates causing invasive disease in adults in Germany.
van der Linden M; Al-Lahham A; Haupts S; Reinert RR
Antimicrob Agents Chemother; 2007 May; 51(5):1830-4. PubMed ID: 17325214
[TBL] [Abstract][Full Text] [Related]
15. Distribution and antibacterial susceptibility of macrolide resistance genotypes in Streptococcus pneumoniae: PROTEKT Year 5 (2003-2004).
Farrell DJ; Couturier C; Hryniewicz W
Int J Antimicrob Agents; 2008 Mar; 31(3):245-9. PubMed ID: 18178388
[TBL] [Abstract][Full Text] [Related]
16. Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes?
Rothermel CD
Clin Infect Dis; 2004 May; 38 Suppl 4():S346-9. PubMed ID: 15127368
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterisation of Hungarian macrolide-resistant Streptococcus pneumoniae isolates, including three highly resistant strains with the mef gene.
Dobay O; Rozgonyi F; Amyes SG
Int J Antimicrob Agents; 2005 Jun; 25(6):488-95. PubMed ID: 15878263
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains.
File TM; Garau J; Jacobs MR; Wynne B; Twynholm M; Berkowitz E
Int J Antimicrob Agents; 2005 Feb; 25(2):110-9. PubMed ID: 15664480
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of the investigational ketolide cethromycin against macrolide- and penicillin-resistant Streptococcus pneumoniae: review of the 1998 to 2006 Canadian Respiratory Organism Susceptibility Study (CROSS).
Wierzbowski AK; Karlowsky JA; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2009 Mar; 63(3):620-2. PubMed ID: 19151038
[No Abstract] [Full Text] [Related]
20. [Bacteremia and meningitis caused by Streptococcus pneumoniae during treatment with azithromycin].
Lisby JG; Brasholt M; Teglbjoerg LL
Ugeskr Laeger; 2002 May; 164(20):2629. PubMed ID: 12043408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]